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Abstract 
Antimicrobial polymers appear as a promising alternative to tackle the current development of bacterial 
resistance against conventional antibiotics as they rely on bacterial membrane disruption. This study 
investigates the effect of segmentation of hydrophobic and cationic functionalities on antimicrobial 
polymers over their selectivity between bacteria and mammalian cells. Using RAFT technology, 
statistical, diblock and highly segmented multiblock copolymers were synthesized in a controlled 
manner. Polymers were analysed by HPLC and the segmentation was found to have a significant 
influence on their overall hydrophobicity. In addition, the amount of incorporated cationic comonomer 
was varied to yield a small library of bioactive macromolecules. The antimicrobial properties of these 
compounds were probed against pathogenic bacteria (Escherichia coli, Pseudomonas aeruginosa, 
Staphylococcus aureus and Staphylococcus epidermidis) and their biocompatibility was tested using 
hemolysis and erythrocyte aggregation assays, as well as mammalian cell viability assays. In all cases, 
diblock and multiblock copolymers were found to outperform statistical copolymers, and for polymers 
with a low content of cationic co-monomer, the multiblock showed a tremendously increased selectivity 
for P. aeruginosa and S. epidermidis compared to its statistical and diblock analogue. This work 
highlights the remarkable effect of segmentation on both, the physical properties of the materials as 
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well as their interaction with biological systems. Due to the outstanding selectivity of multiblock 
copolymers towards certain bacteria strains, the presented materials are a promising platform for the 
treatment of infections and a valuable tool to combat antimicrobial resistance. 
 
Introduction 
 
As an increasing number of studies emphasize the alarming situation concerning life-threatening 
infectious diseases caused by antibiotic resistant bacteria,1-3 health organizations urge for the discovery 
of novel antibiotics.4-6 The development of antimicrobial resistance (AMR) is partly due to the narrow 
range of available antibiotics7 which have reached their limitations in infection treatment because of 
their high target specificity. In such context, antimicrobial peptides (AMPs) have recently attracted 
interest as they were shown to target bacterial membranes instead of individual proteins.8,9 Present in 
the innate immune systems of various organisms, these peptides have an amphipathic structure which 
can adopt a facially amphiphilic arrangement with hydrophobic groups on one side and cationic 
moieties on the other side of the molecule.8 Although the precise mechanism of bacterial killing is still 
under investigation, the cationic groups of the AMPs are thought to bind to the negatively charged 
phospholipids of bacterial membranes via electrostatic interactions, upon which the hydrophobic 
functionalities would induce membrane disruption and lead to cell death.8 Due to the mostly non- 
charged surface of mammalian cells, AMPs exhibit good selectivity towards bacterial membranes. 
However, their isolation or production on a large scale is expensive and their peptidic nature renders 
them vulnerable e.g. to  protease based countermeasures.10 In order to overcome these issues, a wide 
range of synthetic mimics have been developed in recent years from oligomers to polymers using 
different methodologies.11 The key structural parameters which were found to affect antimicrobial 
activity were the choice and balance of cationic to hydrophobic moieties, the molecular weight, the 
nature of the charge and the structure of the polymer backbone.12-23 As the main specifications for 
antimicrobial potency have been elucidated, current research focuses on reducing the toxicity of 
synthetic antimicrobial peptides (SAMPs) against mammalian cells, and more interestingly towards red 
blood cells (RBCs), by investigating new structural parameters.24-26  
 
The activity of peptides is highly dependent on their structural organization,8,27 and mimicking this 
feature, i.e. by self-assembly into nano-sized objects is the next substantial challenge in improving the 
performance of SAMPs. The morphology of core-shell nano particles28 did not affect the antimicrobial 
activity, whereas the size of PEGylated nanoparticles29 reduced both the antimicrobial and the 
hemolytic activity. However, the effect of the shape on the toxicity against mammalian cells was not 
addressed in those studies. Similarly, flower-like micelles30,star-shaped polymers24 and hyperbranched 
polymers31 were shown to be efficient at disrupting bacterial membrane whilst maintaining low 
hemolysis values.  
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Intramolecular interactions of SAMPs were analyzed to a higher extent, since the helical structure of 
certain AMPs was thought to be responsible for their activity. However, it was demonstrated that this 
conformation was not required for SAMPs to exhibit antimicrobial activity. Instead, an amphiphilic 
structure, able to adapt to the cell surface was sufficient for polymers to induce bacterial membrane 
penetration, according to Mowery and co-workers.19 The importance of the conformation of the 
polymers in the potency of SAMPs was highlighted by Nguyen et al.32 using single-chain nanoparticles. 
Similarly, unimolecular aggregates with a cationic shell and a hydrophobic core obtained from the 
folding of amphiphilic copolymers were studied by Oda and co-workers.33 The diblock copolymers 
exhibited a lower hemolytic activity than their random counterpart but an increased hemagglutination, 
demonstrating the effect of the conformation of single polymeric chains on their interactions with cells. 
 
The effect of polymer architecture in SAMPs was investigated by the comparison of diblock copolymers 
with the statistical34 and gradient35 counterparts. The level of hemolytic activity was decreased for 
diblock copolymers in both cases without observing any effect on antimicrobial properties. However, 
the self-assembly of these systems was not analysed, therefore, the difference in the hemolytic activity 
is not necessarily attributed to the sequence but could be related to micelle formation. Indeed, the 
sequence not only strongly affects the self-assemblies of the polymers, but also the folding of the 
polymer chains, hence affecting their physico-chemical properties.36,37 As previously discussed, inter 
and intramolecular assemblies of SAMPs seem to have an important effect on their antimicrobial 
activity and hemocompatibility, but the impact of the monomer sequence beyond diblocks and gradient 
copolymers on these properties has, to the best of our knowledge, yet to be determined for polymers.  
By using multiblock copolymers, systems with a controlled monomer sequence can be obtained.38 By 
varying the degree of segmentation of functional units within a polymer chain an in-depth structure-
activity relationship of the sequence of SAMPs on the antimicrobial activity could be established. Well-
defined multiblock copolymers have been synthesized via various Living Radical Polymerization 
(LRP)39,40 techniques such as Cu(0)-mediated radical polymerization41,42 or Reversible Addition-
Fragmentation chain Transfer (RAFT).43,44 The latter was proven to be a versatile and robust process,39 
compatible with a wide range of monomers and solvents to obtain polymers with narrow molecular 
weight distributions.40 Furthermore, the optimization of the reaction conditions allows for the sequential 
one-pot synthesis of multiblock copolymers.45 As the up-scaling of these synthetic processes has 
recently been explored by using tubular reactors, the availability of SAMPs with a precisely defined 
structure is not an issue.46,47  
The current work focuses on the investigation of multiblock copolymers, which represent an 
intermediate between diblock and statistical copolymers on their performance as SAMPs. 
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Results and discussion 
 
Design and synthesis of SAMPs. Acrylamides were chosen as a monomer class for this study as their 
high propagation rate (kp) allows the synthesis of multiblock copolymers in a straight forward manner 
and their non-degradable nature.44,48 The hydrophobic monomer which was selected for the synthesis 
of SAMPs was N-Isopropylacrylamide (NIPAM) as it mimics the structure of Leucine. Furthermore, 
its hydrophobicity is relatively low compared to monomers which have been used in previous 
studies,49,50 and should therefore, lead to a good  hemocompatibility.51 The cationic amino-acid mimic 
chosen for the design of antimicrobial polymers was an acrylamide-based Lysine mimic: Amino-
EthylAcrylamide (AEAM). To avoid potential aminolysis of the trithiocarbonate group of the CTA 
during the polymerisation process, the Boc-protected equivalent of the monomer (Boc-AEAM)52 (Fig. 
SI-1 and SI-2) was polymerised and a post-polymerisation deprotection method was used to obtain 
functional SAMPs.  
 
As we were interested in the influence of the monomer distribution along the chain on antimicrobial 
activity and toxicity against RBCs, statistical, diblock and multiblock copolymers (Scheme 1) were 
synthesised via RAFT polymerization using different ratios of hydrophobic to cationic pendant groups. 
The SAMPs were named according to their degree of segmentation (H, S, M and D for homopolymer, 
statistical, multiblock and diblock copolymers respectively) and their content of cationic co-monomer 
in % (0, 30, 50, 70 and 100) with protected polymers labelled BOC.  
 
 
Scheme 1. Schematic representation of structure, composition and segmentation of synthesized 
polymers 
 
As the bacterial cell wall might be impermeable to long polymers and hemocompatibility decreased 
with increasing molecular weight the targeted molecular weight of the polymer had to be chosen 
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carefully.53 In this study, the degree of polymerization (DP) was set to 100, as the maximum degree of 
segmentation achievable using a RAFT-based multiblock approach scales with the length of the 
polymer chain.  
The shortest block length that was targeted was DP 10, since it was shown that for DPs below 6, a 
significant number of chains would fail to contain the total number of blocks, according to an analysis 
of the statistical nature of polymer chain growth.54 By taking this limitation into consideration, 
multiblock copolymers were designed with the highest number of blocks compatible for each 
composition. Therefore, seven blocks were targeted for 30 and 70 % BocAEAM content, (M30BOC and 
M70BOC respectively) and ten blocks for M50BOC which has 50 % of BocAEAM (Table SI-1) each in 
an alternating fashion. From the design of these polymers, modifying the structure from statistical to 
multiblock and diblock copolymer will demonstrate the effect of having cationic and hydrophobic 
domains of variable lengths, and segregations, whilst maintaining the overall DP and chemical 
composition. 
(Propanoic acid)yl butyl trithiocarbonate (PABTC) was chosen as the Chain Transfer Agent (CTA) as 
it has previously been used to synthesise multiblock copolymers by maintaining a high livingness.45 
Additionally, the choice of a carboxylic acid based end group has been shown previously to favour 
lower levels of hemotoxicity.55 Optimization of the reaction conditions allowed to reach full conversion 
after each block according to 1H NMR spectroscopy (Fig. SI-3 − 8), to achieve a sequential one-pot 
synthesis of the protected statistical, diblock and multiblock copolymers. The size distribution of the 
protected polymers as determined by SEC was narrow for all synthesized architectures (Table SI-7, Fig. 
1A, Fig. SI-9 − 10). The deprotected polymers could not be analyzed by SEC as they were not soluble 
in the available eluents. The polymers were then quantitatively deprotected using hydrochloric acid as 
supported by the disappearance of the signal associated with the BOC-protecting groups in 1H NMR 
spectra (Fig. 1B, Fig. SI-11 − 12) as well as by the shift of CH2 protons associated with the amine 
pendant groups.  
 
Figure 1. A) DMF-SEC chromatograms for successive chain extensions of M50BOC; B) 1H NMR 
spectra of SAMPs on the example of homopolymers and multiblock copolymers before and after 
deprotection in DMSOd and D2O respectively. 
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Physico-chemical properties of SAMPs. As electrostatic interactions play a major role in the binding 
of SAMPs to bacterial membranes, the polymers have to maintain their positive charge in a 
physiological environment. The cationic properties of the primary amines at physiological pH was 
confirmed by potentiometric titration. Furthermore, by comparing the behaviour of statistical, diblock 
and multiblock copolymers of similar composition, the effect of segmentation on the pKa of the pendant 
groups can be evaluated. The window of pKa of the primary amines of H100 (Fig. SI-13) ranges from 
8 to 11, which was similar to the pKa of the amine group of Lysine at 8.9.56 The range of pKa observed 
for the three copolymers was similar to that of the homopolymer. The majority of the primary amines 
are protonated at physiological pH, rendering the polymers positively charged. However, on the titration 
curves of the polymers (Fig. SI-13), a lower change in the pH was observed with the statistical 
copolymer S30 compared to D30 and M30, when the same amount of base was added. Therefore, S30 
would have a higher buffering capacity than its diblock and multiblock counterpart. Indeed, the 
deprotonation of the primary amines could be facilitated when the groups are statistically distributed 
along the polymer backbone.  
 
While positively charged groups are necessary for the antimicrobial activity of the SAMPs, the balance 
between hydrophilic and hydrophobic groups has arguably the most significant impact on their 
selectivity.11,12 For this reason, the effect of segmentation on this property of SAMPs was analyzed by 
High Performance Liquid Chromatography (HPLC). Non water-soluble diblock and statistical 
copolymers have previously been studied by HPLC, showing that the elution volume varied between 
the two different structures with a similar composition.57 However, to the best of our knowledge, this 
remains the only investigation of the influence of copolymer architecture on the amphiphilic balance. 
A comparison of the amphiphilicity of the various polymers can be established by monitoring their 
elution characteristics, as a higher elution volume indicates a more hydrophobic polymer in a reversed 
phase system (Fig. SI-14 and SI-15). 
For a set architecture (statistical, diblock or multiblock), content of THF necessary to elute the polymer 
decreases with the cationic content (Fig. 2). As expected, the hydrophilicity increases with the amount 
of positive charges along the polymer chain. As NIPAM shows a cloud point behaviour in water58 
measurements at 20 and 60 °C (Fig. SI-16) were carried out and revealed no significant difference in 
the elution volume. For a fixed composition, the hydrophobicity varies with the architecture of the 
SAMPs, with diblock copolymers being most hydrophobic, followed by the multiblock and finally, the 
statistical counterpart. Interestingly, this trend was observed for all three compositions (30, 50 and 70 
% cationic). As the multiblock represents an intermediate level of charge segregation between diblock 
and statistical copolymers, the order at which the polymers elute matches the monomer distribution. 
This observation demonstrates that the hydrophobicity of the polymers does not only depend on their 
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composition but also on the monomer sequence and distribution of isopropyl functionalities along the 
polymer backbone, which could have an impact on their bioactivity.  
 
Figure 2. Elution characteristics of the SAMPs depending on the composition and the architecture by 
HPLC (▲ Diblock copolymers, ● Multiblock copolymers, ■ Statistical copolymers). 
As the amphiphilic properties of the polymers might induce self-assembly,59 Dynamic Light Scattering 
(DLS) was used to investigate the solutions of polymer at 37 °C in Phosphate Buffer Saline (PBS) (Fig. 
SI-19, Table SI-8). The measurements revealed no phase segregation for cationic copolymers, whereas 
particle formation was observed with H0. Therefore, the positively charged primary amine groups 
appear to prevent any particle formation, even for diblock copolymers, which could be a result of the 
electrostatic repulsion. This further supports that the variation in hydrophobicity depending on the 
polymer architecture is not associated with intermolecular interactions.  
Dye leakage study. Before investigating the antimicrobial activity, the ability of the SAMPs to disrupt 
bacterial membranes was examined using a dye leakage assay. Liposomes mimicking Gram-positive 
and Gram-negative bacterial membranes were loaded with a fluorescent dye which signals membrane 
disruption. All polymers, except for H0, showed an increase in fluorescence against both Gram-positive 
(Fig. SI-17) and Gram-negative (Fig. 3 and SI-18) membrane models. Additionally, as the charge 
content of SAMPs increases, so does the induced leakage in most cases, which demonstrates the 
importance of electrostatic interactions in this process. Statistical, multiblock and diblock copolymers 
exhibited similar dye leakage profiles. Although this assay is not quantitative as demonstrated by Tew 
et al.,53 it shows that the SAMPs are membrane active independent of their architecture.  
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Figure 3. Dye leakage study with multiblock copolymers (M30, M50 and M70) and the homopolymers 
H0 and H100 on Gram-negative bacteria model. Fluorescence was read at 537 nm (emission) at an 
excitation wavelength of 492 nm. The sample was added at 30 s measurement time and vesicles were 
lysed by addition of Triton X at 9 min.  
 
Antibacterial susceptibility assays. Growth inhibition was studied using two strains of Gram-negative 
bacteria: Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa); and two Gram-
positive strains: Staphylococcus aureus (S. aureus) and Staphylococcus epidermidis (S. epidermidis). 
For statistical and diblock copolymers, the antimicrobial activity against all four strains increased with 
the cationic content as shown on Table 1, which is consistent with previous investigations.15 For 
multiblocks, no clear trend could be established. 
Interestingly, for the set of polymers with 30 % charge, a drastic reduction of the MIC was observed 
from the statistical copolymer (S30), which was inactive towards most bacterial strains tested 
(MIC>1024μg mL-1, except against S. epidermidis with MIC=32 μg mL-1) , to diblock and heptablock 
(D30 and M30), showing MIC values as low as 4 ug mL-1. Across the four bacterial strains, Gram-
negative bacteria such as P. aeruginosa were particularly affected by the polymer architecture, with 
MICs decreasing from over 1000 (S30) to 32 and 8 μg mL-1 for D30 and M30 respectively (Fig. SI-20), 
which could be due to the difference in the composition60 of their bacterial cell envelope. Gram-negative 
bacteria possess an outer membrane (OM), which is a lipid bilayer comprised of an outer leaflet of 
lipopolysaccharides and of an inner leaflet of phospholipids.61 As the lipopolysaccharides have long 
saturated acyl chains (leading to an increased membrane stiffness) combined with hydrophilic 
saccharides, they offer a protective barrier which renders Gram-negative bacteria difficult targets. The 
variations in the physico-chemical properties due to the monomer sequence, as monitored by HPLC, 
could hence alter the disruption of this OM. The presence of hydrophilic domains in the block 
copolymers, as compared to the broad distributions of the cationic pendant groups in the statistical 
copolymers might lead to an increased efficiency of the interaction of the macromolecules with the 
hydrophilic outer layer of the OM. The overall hydrophilicity of the polymer, which was shown to differ 
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between architectures using HPLC, could also have an influence. However, the improvement of the 
OM permeabilization of Gram-negative bacteria with segmented systems seems unlikely to be related 
to the increase in the hydrophobicity of the polymers with the segmentation. 
Table 1. Antimicrobial activity, hemolytic activity and hemagglutination of antimicrobial polymers. 
 
Sample  
HC
10
[a] 
(μg mL-1) 
c
 H
 [b] 
(μg mL-1) 
MIC[c] (μg mL-1) Selectivity[d] 
E. coli 
P. 
aeruginosa 
S. 
aureus 
S. 
epidermidis 
E. coli 
P. 
aeruginosa 
S. 
aureus 
S. 
epidermidis 
H0 > 1024 > 1024 > 1024 > 1024 > 1024 > 1024 > 1 > 1 > 1 > 1 
H100 512 16 4 4 4 32 4 4 4 0.5 
S30 > 1024 32 > 1024 > 1024 > 1024 32 0.03 0.03 0.03 1 
S50 > 1024 32 64 128 8 2 0.5 0.25 4 16 
S70 > 1024 32 64 64 4 2 0.5 0.5 8 16 
M30 > 1024 > 1024 128 8 64 4 > 8 > 128 > 16 > 256 
M50 > 1024 32 1024 64 32 8 0.03 0.5 1 4 
M70 > 1024 32 1024 32 4 4 0.03 1 8 8 
D30 > 1024 > 1024 512 32 128 32 > 2 > 32 > 8 > 32 
D50 > 1024 > 1024 64 64 8 4 > 16 > 16 > 128 > 256 
D70 > 1024 > 1024 32 32 8 4 > 32 > 32 > 128 > 256 
[a] HC10 is the minimum concentration at which at least 10 % of the maximum lysis was observed 
[b] cH is the lowest concentration at which the polymers induce aggregation of RBCs 
[c] MIC is the minimum inhibitory concentration at which no visible bacteria growth can be observed. 
[d] Selectivity: lowest value between HC10 and cH (hemocompatibility concentration) divided by the MIC of the 
bacterial strains concerned. 
 
Hemocompatibility of SAMPS. Although the main target is to obtain SAMPs with high potency 
against bacteria, their toxicity towards mammalian cells has to be minimized to be considered for any 
human health application. Since blood is the principal vector distributing active compounds to cells, a 
focus has been drawn to the toxicity of SAMPs towards RBCs. The first assay was directed towards the 
investigation of the lysis of the RBCs in presence of the polymers, since they were shown to be 
membrane active according to the dye leakage studies. The hemolytic concentration HC10 
(concentration to elicit 10 % hemolysis), was determined at concentrations between 2 and 1024 μg mL-
1 with only H100 disrupting RBCs (Table 1, Fig. SI-21), which is a result of the limited hydrophobicity 
of NIPAM compared to having pendant alkyl chains of 4 carbons and more.  
To obtain a complete picture of the hemocompatibility of the polymers, hemagglutination, which is not 
necessarily related to hemolysis was studied as well since positively charged polymers can interact with 
negatively charged sialic acid groups at the surface of RBCs, leading to intercellular binding.17 The 
hemagglutination concentration cH, which is the lowest concentration to induce agglutination of RBCs,33 
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was determined (Table 1,Table SI-9). In line with the study of Locock and co-workers,17 H100 induced 
hemagglutination at low concentration, whereas no aggregates were observed for H0, which confirms 
the hemocompatibility of polyNIPAM. Interestingly, the three diblock copolymers (D30, D50 and D70) 
as well as M30, had cH values of over 1000 μg mL-1. Therefore, with similar cationic content, these 
SAMPs did not induce any hemagglutination, as opposed to their statistical counterparts. These results 
could be explained by cationic moieties being distributed over the full length of the chain, as for 
statistical and multiblock copolymers, rendering cross-linking between RBCs more likely as opposed 
to diblock copolymers for which the charges are concentrated on a single segment of the 
macromolecule. These results highlight the importance of charge segregation in the interaction with 
RBCs. Furthermore, according to HPLC data (Fig. 2), the four cationic copolymers which did not induce 
any hemagglutination, are the most hydrophobic SAMPs, hence a correlation between these parameters 
is possible.  
Using the data obtained by probing the hemocompatibility of the presented polymers, a selectivity value 
was determined for each bacterial strains using the ratio between the hemocompatibility concentration 
(which is the lowest value of HC10 and cH, Table SI-10) and the MIC against the specific strains (Table 1, 
Fig. 4). This value is a powerful tool to assess the potential of antimicrobial substances, as only those 
with a pronounced activity against bacteria and which do not affect RBCs will have high selectivity 
values.18 As none of the SAMPs exhibit distinct hemolytic potency, hemagglutination concentration 
was used to calculate the selectivity (Equation 1, Table 1).  
𝑆𝑒𝑙𝑒𝑐𝑡𝑖𝑣𝑖𝑡𝑦 =
𝑐𝐻
𝑀𝐼𝐶
 
Equation 1. Determination of the selectivity against RBCs for a specific bacterial strain. 
Increasing the cationic content improves the selectivity for statistical and diblock copolymers with all 
four species of bacteria studied. Fig. 4 illustrates the selectivity of the SAMPs by dividing them into 
categories with the most inactive and hemotoxic polymers in the bottom-right corner (highlighted in 
red; IV), most potent and hemocompatible species in the top-left corner (I), and two yellow intermediate 
zones in the top-right (II) and bottom-left (III) corner being the inactive but hemocompatible polymers 
and active but hemotoxic ones, respectively. The most selective polymers for the four different bacterial 
strains appear to be the diblocks (D30, D50 and D70) and the multiblock copolymer M30. The largest 
variation with segmentation was observed for SAMPs with a charge content of 30%, with S30 being in 
the red corner (IV) for all the bacterial species, except S. epidermidis, as opposed to M30 and D30 
which were highly active and hemocompatible. For 50 and 70 % cationic SAMPs, the selectivity also 
improved from statistical and multiblock to diblock due to an increased hemocompatibility. By altering 
the polymer sequence, thus charge segregation, the selectivity with RBCs can be drastically modified 
whilst maintaining the same composition.  
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Figure 4. Selectivity of the SAMPs with RBCs against E. coli (A), P. aeruginosa (B), S. aureus (C) 
and S. epidermidis (D). 
Biocompatibility of SAMPs. Potential applications for the SAMPs include their use as wound 
dressings or as oral antibiotics. As such, murine embryonic fibroblasts (NIH 3T3) and human colorectal 
epithelial (Caco2) cells were used to further determine the biocompatibility of the SAMPs. NIH 3T3 
are one of the most commonly used fibroblast cell lines, a type of cell that is part of the connective 
tissue of animals, and is involved in the synthesis of the extracellular matrix thus playing a critical role 
in wound healing. Additionally, Caco2 cells are well characterised colorectal cells that can be used as 
a model for intestinal absorption.62 
To determine the ability of the compounds to inhibit cell proliferation, NIH 3T3 and Caco2 cells were 
incubated with polymer concentrations ranging from 32 to 1024 μg mL-1 for 3 days. As expected, H0 
displayed no toxicity at any of the concentrations used, while H100 showed pronounced interference 
with the cell viability (Fig. SI-22) for both cell lines. The Inhibitory Concentration (IC50) values, which 
are the polymer concentrations inhibiting growth of 50 % of the cells, were calculated for NIH 3T3 and 
Caco2 (Table SI-11, Fig. 5) using the toxicity curves from Figure SI-22. As expected, an increasing 
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content of cationic groups per polymer chain led to an increased toxicity in both cell lines, which is 
similar to the trend observed with hemotoxicity results. This could be attributed to the membrane 
activity of the polymers. Additionally, the SAMPs were more toxic on Caco2 cells than NIH 3T3 cells, 
which might be due to increased uptake by the colorectal cells. According to Fig. 5, for polymers with 
30 % of charged co-monomer, the IC50 increases from D30 to M30, followed by S30 with Caco2 cells.  
 
Figure 5. IC50 of the SAMPs for A) NIH 3T3 and B) Caco2 cells after incubation at 37˚C for 72 h by 
XTT assay. 
These cytotoxicity results seem to direct potential application of the SAMPs towards skin wound 
treatment rather than oral use. Therefore, the following discussions relative to cytotoxicity will be based 
on the results obtained with NIH 3T3 cells. Similarly to the selectivity calculated for the RBCs, the 
therapeutic index (TI) was obtained from the ratio of the IC50 for the mammalian cells to the MIC for 
each bacteria strain63 (Equation 2, Table SI-11) and graphs representing the IC50 against the MIC 
illustrated the TI for NIH 3T3 (Fig. SI-23).  
𝑇𝐼 =
𝐼𝐶50
𝑀𝐼𝐶
 
Equation 2. Determination of the TI with a cell line for a specific bacteria species. 
From Fig. SI-23, M30 appears to be the ideal candidate against the four strains of bacteria when taking 
into account the toxicity towards NIH 3T3 cells. Indeed, at 30 % charge, the segmentation allowed for 
the improvement of the selectivity of S30 (being non-toxic but poorly active) to D30 and M30 
(exhibiting low toxicity and high potency). Although D50 and D70 were shown to be as selective as 
M30 with RBCs, their selectivity towards NIH 3T3 was much lower, as displayed in Fig. SI-23.  
The overall performance was analysed by illustrating the TI of the SAMPs for NIH 3T3 cells against 
the selectivity for the different bacterial species over RBCs (Fig. 6 only displays polymers with a value 
of at least 1 for both parameters, whereas Fig. SI-24 represents the full plot). The most selective 
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polymers are located in the top-right green corner which represents the SAMPs of selectivity and TI of 
10 and above. The highest values regarding the selectivity of the three mammalian cells combined were 
associated with M30 for both P. aeruginosa and S. epidermidis.  
 
Figure 6. TI of the SAMPs with NIH 3T3 cells against their selectivity with RBCs for E. coli (A), P. 
aeruginosa (B), S. aureus (C) and S. epidermidis (D). 
This finding highlights the importance of segmentation on the overall performance of these materials 
as despite similar chemical composition M30 outperforms S30 and D30. The multiblock copolymer 
shows a low tendency of erythrocyte aggregation and does interfere less with mammalian cell viability 
as compared to its diblock analogue, while maintaining a high membrane activity against pathogenic 
bacteria. It needs to be emphasized that presented polymers show a pronounced activity against Gram-
negative bacteria despite the presence of an OM which confers a protective barrier to these bacteria. 
This renders this class of SAMPs a highly promising candidate for the treatment of infections, as the 
antibiotic pipeline for this type of bacteria is depleting rapidly. Their excellent compatibility with 
fibroblasts renders them interesting candidates as antimicrobial material in wound healing treatments. 
14 
 
Bacterial resistance. One of the main issues with currently used antibiotics is the ability of bacteria to 
develop resistance against them, rendering the antibiotics inactive after an extended contact of bacteria 
with non-lethal doses.1 However, as previously mentioned, bacteria cannot acquire resistance against 
SAMPs as easily, since the polymers seem to act directly on the cellular membrane. In order to 
demonstrate the potential of the SAMPs as an alternative to currently used antibiotics, the development 
of the MIC was studied for S30, M30 and D30 against a MRSA strain (USA 300) over 4 weeks of 
exposure at a concentration of a tenth of the MIC (one passage per day). The antibacterial activity did 
not vary throughout the assay (Fig. SI-25) and no resistant mutants could be detected by incubating the 
final bacterial suspension. Therefore, the development of resistance against these polymers by bacteria 
is not easily acquired, which is independent of the segmentation. This indicates a similar, membrane 
based mechanism for the herein presented SAMPs. 
 
Conclusion. 
Synthetic antimicrobial peptides (SAMPs) based on a cationic (AEAM) and a hydrophobic co-monomer 
(NIPAM) with various degrees of segmentation were synthesised by exploiting RAFT multiblock 
technology. From our study, the segmentation of the monomer distribution appeared to have an impact 
on various levels. Firstly, the hydrophobicity of the polymers increased with the length of the blocks, 
thus introducing an additional handle for tuning of this parameter. Furthermore, antimicrobial activity 
was dependent on the sequence at low contents of cationic co-monomer, particularly with Gram-
negative bacteria, which could be a result of an increased interaction of the cationic moieties with the 
outer membrane of bacteria, when these functionalities are organised in domains. Additionally, this 
study has shown that NIPAM is a co-monomer of choice as no hemolytic activity was observed, whilst 
the antimicrobial potency of the copolymers was maintained.  
By cross-examination of the selectivity towards erythrocytes, epithelial cells and fibroblasts, the 
biocompatibility of the SAMPs was further investigated. In all cases, diblock copolymers were found 
to outperform statistical copolymers, and at low incorporation of cationic co-monomer, the multiblock 
showed a tremendously increased selectivity for P. aeruginosa and S. epidermidis compared to its 
statistical and diblock analogue. These results are independent to any self-assembling behaviour as, 
within the tested concentrations, the SAMPs are in their unimolecular form. The multiblock technology 
allowed us to highlight the remarkable effect of charge segregation on both, the physical properties of 
the materials as well as their interaction with biological systems. The performance of these SAMPs 
demonstrates their potential as alternatives to standard antibiotics for wound treatment, as these 
polymers possess a low toxicity towards mammalian cells and do not seem to generate bacterial 
resistance. 
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